Understanding the UMAB Drug: A Guide to Fully Human Monoclonal Antibodies
•
5 min read
Over 100 monoclonal antibody therapies have been approved by the FDA since 1986, revolutionizing treatment for a variety of conditions. In pharmacology, the suffix **-umab** on a drug's generic name provides a critical clue, indicating that it is a fully human monoclonal antibody. This design is a key advancement aimed at improving therapeutic effectiveness and minimizing side effects by maximizing compatibility with the human immune system.
